OpenAI Chief Executive Officer Sam Altman said his company may consider investing in or subsidizing firms that make ...

In return, OpenAI could receive royalties from the revenue generated by these new drugs. The investment by OpenAI could ...

As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma ...

Researchers from The Ohio State University and the Indian Institute of Technology Madras have developed an artificial intelligence framework to rapidly generate drug-like molecules that are easier to ...

Inductive Bio, an AI drug discovery partner developing virtual chemistry labs, has won the OpenADMET-ExpansionRx blind challenge with its Beacon models, placing first among more than 370 submissions ...

Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

AI has fundamentally altered the feasibility of natural product discovery from fungal endophytes. Advances in genome ...

A Google DeepMind invention that uses artificial intelligence (AI) to predict how DNA mutations behave could have a ...

This pharmaceutical giant is increasingly looking unstoppable.

Nanyang Biologics Pte. Ltd., together with its subsidiaries (collectively, the "Company", "we" or "NYB"), offers a comprehensive drug discovery platform that integrates the wisdom of traditional ...

Nvidia is no longer content to be the chip supplier behind other companies’ biotech ambitions. With a multibillion dollar ...

A new generation of artificial intelligence is starting to read the human genome with a fluency that would have sounded like ...